TerrAscend (TSNDF) Receivables - Net (2021 - 2026)
TerrAscend's (TSNDF) quarterly Receivables - Net came in at $16.0 million in Q1 2026, down 14.49% year-on-year from $18.8 million in Q1 2025, and down 5.4% on a QoQ basis from $17.0 million in Q4 2025.
TerrAscend (TSNDF) Receivables - Net (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Receivables - Net data on file, last reported at $16.0 million in Q1 2026.
- On a quarterly basis, Receivables - Net fell 14.49% year-over-year to $16.0 million in Q1 2026; TTM through Mar 2026 was $16.0 million, a 14.49% decrease from a year earlier, with the FY2025 full-year figure at $17.0 million, down 16.13% from the prior year.
- Receivables - Net for Q1 2026 stood at $16.0 million, down from $17.0 million in the prior quarter.
- Over the last five years, Receivables - Net for TSNDF reached as high as $23.1 million in Q1 2022 and fell as low as $15.0 million in Q3 2023.
- Historically, Receivables - Net has averaged $18.7 million across 5 years, with a median of $18.4 million in 2023.
- Across the five-year window, Receivables - Net jumped 79.62% in 2022 and fell 20.36% in 2023, its largest moves.
- Year by year, Receivables - Net stood at $22.4 million in 2022, then retreated by 15.13% to $19.0 million in 2023, then increased by 6.17% to $20.2 million in 2024, then dropped by 16.13% to $17.0 million in 2025, then fell by 5.4% to $16.0 million in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $16.0 million in Q1 2026, $17.0 million in Q4 2025, and $17.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.05 Mn |
| Mar 31, 2026 | 16.05 Mn |
| Dec 31, 2025 | 16.96 Mn |
| Dec 31, 2025 | 16.96 Mn |
| Sep 30, 2025 | 17.12 Mn |
| Sep 30, 2025 | 17.12 Mn |
| Jun 30, 2025 | 19.99 Mn |
| Jun 30, 2025 | 19.99 Mn |
| Mar 31, 2025 | 18.77 Mn |
| Mar 31, 2025 | 18.77 Mn |
| Dec 31, 2024 | 20.22 Mn |
| Dec 31, 2024 | 20.22 Mn |
| Sep 30, 2024 | 17.57 Mn |
| Sep 30, 2024 | 17.57 Mn |
| Jun 30, 2024 | 16.81 Mn |
| Jun 30, 2024 | 16.81 Mn |
| Mar 31, 2024 | 17.01 Mn |
| Mar 31, 2024 | 17.01 Mn |
| Dec 31, 2023 | 19.05 Mn |
| Dec 31, 2023 | 19.05 Mn |